The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cited by
Items 101–150 of 150
Reavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., et al. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39184-0 · Cited by 287
Dewey, S. L., Smith, G. S., Logan, J., Brodie, J. D., Fowler, J. S., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890130407 · Cited by 283
The role of dopamine in epilepsy
Starr, M. S. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199602)22:2<159::aid-syn8>3.0.co;2-c · Cited by 278
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene.
Crocq, M. A., Mant, R., Asherson, P., Williams, J., Hode, Y., Mayerova, A., Collier, D., Lannfelt, L., Sokoloff, P., & Schwartz, J. C. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.12.858 · Cited by 277
Self-citationNeurobiology of retinal dopamine in relation to degenerative states of the tissue
Djamgoz, M. B. A., Hankins, M. W., Hirano, J., & Archer, S. N. (1997) · Vision Research · doi:10.1016/s0042-6989(97)00129-6 · Cited by 274
Psychopharmacologic Treatment of Schizophrenia
Kane, J. M., & Marder, S. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.287 · Cited by 273
Impulse Control and Related Disorders in Parkinson's Disease
Weintraub, D., & Claassen, D. O. (2017) · International Review of Neurobiology · doi:10.1016/bs.irn.2017.04.006 · Cited by 272
Khan, Z. U., Guti�rrez, A., Mart�n, R., Pe�afiel, A., Rivera, A., & De La Calle, A. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981221)402:3<353::aid-cne5>3.0.co;2-4 · Cited by 271
Huang, Q., Zhou, D., Chase, K., Gusella, J. F., Aronin, N., & DiFiglia, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11988 · Cited by 265
Sulpiride: an Antipsychotic with Selective Dopaminergic Antagonist Properties
Caley, C. F., & Weber, S. S. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900210 · Cited by 264
Pyrrole: An insight into recent pharmacological advances with structure activity relationship
Ahmad, S., Alam, O., Naim, M. J., Shaquiquzzaman, M., Alam, M. M., & Iqbal, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.002 · Cited by 259
Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism
Piomelli, D., Pilon, C., Giros, B., Sokolofff, P., Martres, M.-P., & Schwartz, J.-C. (1991) · Nature · doi:10.1038/353164a0 · Cited by 258
Self-citationPramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors
Mierau, J., Schneider, F. J., Ensinger, H. A., Chio, C. L., Lajiness, M. E., & Huff, R. M. (1995) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(95)90013-6 · Cited by 257
Pharmacokinetics and Pharmacodynamics of Clozapine
Jann, M. W., Grimsley, S. R., Gray, E. C., & Chang, W.-H. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324020-00005 · Cited by 257
Molecular neurobiology of dopaminergic receptors
Sibley, D. R., Monsma, F. J., & Shen, Y. (1993) · International review of neurobiology · doi:10.1016/s0074-7742(08)60573-5 · Cited by 255
Hippocampal modulation of sensorimotor processes
Bast, T., & Feldon, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00112-6 · Cited by 255
The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity
Waters, N., Svensson, K., Haadsma-Svensson, S. R., Smith, M. W., & Carlsson, A. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244979 · Cited by 255
Arnsten, A., Cai, J., Steere, J., & Goldman-Rakic, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03429.1995 · Cited by 254
Chapter 10 Functional roles of dopamine in the vertebrate retina
Witkovsky, P., & Dearry, A. (1991) · Progress in Retinal Research · doi:10.1016/0278-4327(91)90031-v · Cited by 252
Boileau, I., Payer, D., Chugani, B., Lobo, D. S. S., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., & Zack, M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.163 · Cited by 198
Opponent Process Model and Psychostimulant Addiction
Koob, G. F., Caine, S. B., Parsons, L., Markou, A., & Weiss, F. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00438-8 · Cited by 196
Boileau, I., Payer, D., Chugani, B., Lobo, D., Behzadi, A., Rusjan, P. M., Houle, S., Wilson, A. A., Warsh, J., Kish, S. J., et al. (2013) · Addiction · doi:10.1111/add.12066 · Cited by 190
Swanson, C. J., Heath, S., Stratford, T. R., & Kelley, A. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00043-9 · Cited by 176
Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man
Farde, L., Hall, H., Pauli, S., & Halldin, C. (1995) · Synapse · doi:10.1002/syn.890200303 · Cited by 175
Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04627.1999 · Cited by 174
Watson, D. J., Loiseau, F., Ingallinesi, M., Millan, M. J., Marsden, C. A., & Fone, K. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.254 · Cited by 151
KUROKI, T., NAGAO, N., & NAKAHARA, T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00910-2 · Cited by 146
Repeated sucrose access influences dopamine D2 receptor density in the striatum
Bello, N. T., Lucas, L. R., & Hajnal, A. (2002) · Neuroreport · doi:10.1097/00001756-200208270-00017 · Cited by 144
Molteni, R., Calabrese, F., Bedogni, F., Tongiorgi, E., Fumagalli, F., Racagni, G., & Andrea Riva, M. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005766 · Cited by 132
Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1166 · Cited by 123
Drd3 Signaling in the Lateral Septum Mediates Early Life Stress-Induced Social Dysfunction
Shin, S., Pribiag, H., Lilascharoen, V., Knowland, D., Wang, X.-Y., & Lim, B. K. (2018) · Neuron · doi:10.1016/j.neuron.2017.11.040 · Cited by 120
Phillips, G. D., Robbins, T. W., & Everitt, B. J. (1994) · Psychopharmacology · doi:10.1007/bf02249339 · Cited by 116
Depression and impulse control disorders in Parkinson׳s disease: two sides of the same coin?
Vriend, C., Pattij, T., van der Werf, Y. D., Voorn, P., Booij, J., Rutten, S., Berendse, H. W., & van den Heuvel, O. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.001 · Cited by 106
Bari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105
“Rreaction time variability”
BackgroundRetz, W., R�sler, M., Supprian, T., Retz-Junginger, P., & Thome, J. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0805-5 · Cited by 100
Huntley, G. W., Morrison, J. H., Prikhozhan, A., & Sealfon, S. C. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90107-m · Cited by 100
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target
Steckelings, U. M., Widdop, R. E., Sturrock, E. D., Lubbe, L., Hussain, T., Kaschina, E., Unger, T., Hallberg, A., Carey, R. M., & Sumners, C. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000281 · Cited by 97
Mercuri, N. B., Calabresi, P., & Bernardi, G. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90479-9 · Cited by 86
The current status of association studies in obsessive-compulsive disorder
Hemmings, S. M. J., & Stein, D. J. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.02.011 · Cited by 83
Papp, M., Muscat, R., & Willner, P. (1993) · Psychopharmacology · doi:10.1007/bf02246965 · Cited by 79
“1991), a selective agonist at the D 2 (Fuller and Hemrick-Luecke 1985), and possibly D 3 ( Sokoloff et al. 1990 ), DA receptor subtypes.”
BackgroundCaprioli, D., Hong, Y. T., Sawiak, S. J., Ferrari, V., Williamson, D. J., Jupp, B., Adrian Carpenter, T., Aigbirhio, F. I., Everitt, B. J., Robbins, T. W., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.44 · Cited by 58
The neuroanatomy of schizophrenia: circuitry and neurotransmitter systems
Fallon, J. H., Opole, I. O., & Potkin, S. G. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00022-7 · Cited by 53
Ferger, B., Kropf, W., & Kuschinsky, K. (1994) · Psychopharmacology · doi:10.1007/bf02244852 · Cited by 55
Papp, M., Willner, P., & Muscat, R. (1993) · Psychopharmacology · doi:10.1007/bf02246966 · Cited by 47
Joyce, J. N. (2001) · Synapse · doi:10.1002/syn.1035 · Cited by 47
Candidate gene studies of bipolar disorder
Jones, I., & Craddock, N. (2001) · Annals of Medicine · doi:10.3109/07853890108998753 · Cited by 44
Role of Glial Cells in Neuronal Function, Mood Disorders, and Drug Addiction
Tizabi, Y., Getachew, B., Hauser, S. R., Tsytsarev, V., Manhães, A. C., & da Silva, V. D. A. (2024) · Brain Sciences · doi:10.3390/brainsci14060558 · Cited by 27
Management of impulse control disorders in Parkinson's disease
Zhang, S., Dissanayaka, N. N., Dawson, A., O'Sullivan, J. D., Mosley, P., Hall, W., & Carter, A. (2016) · International Psychogeriatrics · doi:10.1017/s104161021600096x · Cited by 22
Role of the D3 dopamine receptor in nicotine sensitization
Smith, L. N., Bachus, S. E., McDonald, C. G., & Smith, R. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.025 · Cited by 16
Dopamine Type 2/3 Receptor Availability in the Striatum and Social Status in Human Volunteers
Martinez, D., Orlowska, D., Narendran, R., Slifstein, M., Liu, F., Kumar, D., Broft, A., Van Heertum, R., & Kleber, H. D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.037 · Cited by 146
“[11C]Raclopride has a similar affinity for D2 and D3 receptors (17), and the signal from these receptors cannot be distinguished.”
Metadata
- Authors
- Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C.
- Venue
- Nature
- Published
- 1990-09
- Volume
- 347
- Issue
- 6289
- Pages
- 146-151
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1966092598
- Cited by
- 2,609
- References
- 44
- FWCI
- 67.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.